High-Performance Liquid Chromatography (HPLC) Market: Current Analysis and Forecast (2021-2027)
Emphasis on Product (Instruments (System, Detector), Consumables (Column, Filter), Accessories); Application (Clinical Research, Diagnostics, Forensics); Region/Country
High-Performance Liquid Chromatography (HPLC) Market is expected to grow at a CAGR of around 5% over the forecast period (2021-2027). Increased use of high-performance liquid chromatography in biological research, rising research and development activities, growing number of pharmaceutical companies and contract research institutes, high prevalence of chronic diseases, and rising investment in life sciences and academics all contribute to the market’s growth.
The top ten causes of death accounted for 55% of the world’s 55.4 million deaths in 2019. The top three global causes of death are cardiovascular (ischaemic heart disease, stroke), respiratory (chronic obstructive pulmonary disease, lower respiratory infections), and neonatal conditions, which include birth asphyxia and trauma, neonatal sepsis and infections, and preterm birth complications, in order of total number of lives lost. Noncommunicable illnesses accounted for seven of the top ten causes of death worldwide in 2019. These seven factors accounted for 44% of all deaths, or 80% of the top ten.
Hence, the drug discovery for these ailments needs to be performed regularly. The pharmaceutical industry’s lifeblood is research and development. Major drug firms’ performance is nearly entirely dependent on the research and development of new medications, and their capital expenditures (capex) allocation reflects this fact. Although the average company spends more than 25% of its revenue, other such companies spend far more. In 2018 and 2019, pharmaceutical businesses spent over 25% of their revenues on R&D, making them one of the major spenders in this field. In fact, the pharmaceutical business accounts for over half of the world’s top 20 R&D spending industries. AstraZeneca and Eli Lilly, two other big players in the business, each spent $6 million on R&D.
Top Pharma Companies R&D Spending, (USD Billion), 2020
Some of the major players operating in the market include Thermo Fisher, PerkinElmer, GE Healthcare, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Hitachi, Merck Millipore, Shimadzu Corporation, Showa Denko, Waters Corporation, etc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions.
Insights Presented in the Report
“Amongst Product, Instruments segment dominated the market in 2020”
By Product, High-Performance Liquid Chromatography (HPLC) Market is classified the market is segmented into Instruments, Consumables, and Accessories. The Instruments segment leads the High-Performance Liquid Chromatography (HPLC) Market. The large share of the Instruments segment can be attributed to the competitive pricing offered by device manufacturers. In addition, technological advancements and growing acceptance of HPLC devices also boost the market growth over the forecast period. However, Consumables register the highest growth over the forecast period.
“Amongst Application, Clinical Research segment dominated the market in 2020.”
Based on Application, the High-Performance Liquid Chromatography (HPLC) market is segmented into Clinical Research, Diagnostics, and Forensics. The Clinical Research segment contributed the maximum market to the High-Performance Liquid Chromatography (HPLC) market. Increasing use of High-Performance Liquid Chromatography (HPLC) systems in clinical & pre-clinical pharma activities drives the market growth.
“North America represents as the largest market.”
For a better understanding of the market adoption of High-Performance Liquid Chromatography (HPLC) systems, the market is analyzed for the countries such as North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), & Rest of World. North America dominated the market in 2020. The increase in R&D and preclinical activities by pharmaceutical companies, robust healthcare infrastructure, high adoption rate of technologically advanced products, and an increase in healthcare expenditure in the region also contributes to the market’s growth.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional & country-level analysis of the industry
Customization Options:
High-Performance Liquid Chromatography (HPLC) Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Analyzing the historical market, estimation of the current market, and forecasting the future of the High-Performance Liquid Chromatography (HPLC) Market were the three major steps undertaken to create and analyze the adoption of High-Performance Liquid Chromatography (HPLC) systems across various regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted, with industry experts across the value chain of the industry. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below.
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detailed secondary study was conducted to obtain the historical market size of High-Performance Liquid Chromatography (HPLC) through company internal sources such as annual report & financial statements, investor presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the High-Performance Liquid Chromatography (HPLC), we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report are by products and application. Further regional & country-level analyses were conducted to evaluate the overall adoption of the High-Performance Liquid Chromatography (HPLC) Market in the global context.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size. Further, we conducted factor analysis using dependent and independent variables such as high sensitivity and accuracy of the HPLC technique, the rising importance of HPLC tests in drug approvals, the growing popularity of hyphenated techniques, etc. Historical trends and their year-on-year impact on the market size and share was analyzed. Demand and supply side scenario was also thoroughly studied.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Market, and market shares of the segments and company. All the required percentage split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast to 2027 for different segments and subsegments across the major regions globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of value (US$)
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the High-Performance Liquid Chromatography (HPLC) Market in terms of products & services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major countries. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of High-Performance Liquid Chromatography (HPLC) Market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of products and application for the major country/region globally.
The main objective of the High-Performance Liquid Chromatography (HPLC) Market Study
The current & future market trends of High-Performance Liquid Chromatography (HPLC) were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a regional & country level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of High-Performance Liquid Chromatography (HPLC) in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include of Products and Application
- Analyze the current and forecast market size of the High-Performance Liquid Chromatography (HPLC) for the major regions & countries
- Major regions studied in the report include North America (United States, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), and Rest of World
- Company profiles of the High-Performance Liquid Chromatography (HPLC) Market players and the growth strategies adopted by them to sustain in the fast-growing market
Deep dive regional & country level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
